0000904454-14-000339.txt : 20140321
0000904454-14-000339.hdr.sgml : 20140321
20140321194612
ACCESSION NUMBER: 0000904454-14-000339
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140319
FILED AS OF DATE: 20140321
DATE AS OF CHANGE: 20140321
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CADENCE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001333248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8584361400
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kamdar Kim P.
CENTRAL INDEX KEY: 0001535065
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33103
FILM NUMBER: 14711624
MAIL ADDRESS:
STREET 1: C/O DOMAIN ASSOCIATES, L.L.C.
STREET 2: ONE PALMER SQUARE, SUITE 515
CITY: PRINCETON
STATE: NJ
ZIP: 08542
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-03-19
1
0001333248
CADENCE PHARMACEUTICALS INC
CADX
0001535065
Kamdar Kim P.
C/O DOMAIN ASSOCIATES, LLC
ONE PALMER SQUARE
PRINCETON
NJ
08542
0
0
1
0
Common Stock
2014-03-19
4
D
0
27500
14.00
D
0
I
By Domain Associates, LLC
In connection with the acquisition of the Issuer by Mallinckrodt plc ("Parent") on March 19, 2014, and pursuant to the terms of the Agreement and Plan of Merger by and among the Issuer, Parent and Madison Merger Sub, Inc. ("Merger Sub") dated February 10, 2014, Merger Sub acquired all of the issued and outstanding shares of Common Stock (the "Shares") for a purchase price of $14.00 per Share.
The Reporting Person is a Managing Member of Domain Associates, LLC. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
/s/Kathleen K. Schoemaker, Attorney-in-Fact
2014-03-21